Bropirimine
- Level
- Commodity
- Parent
- 51201800
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51201814This classification denotes an immunostimulant with the molecular formula C10H8BrN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J57CTF25XJ, chemically known as 4-pyrimidinol, 2-amino-5-bromo-6-phenyl- but generally known as bropirimine, which bears US NIH Compound Identifier 65457. European Medicines Agency schedules Bropirimine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05928MIG. The term BROPIRIMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). BROPIRIMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bropirimine under HS 29335995 and SITC 51576. As of Q4 2014, BROPIRIMINE remains the US FDA Preferred Term for this commodity. Bropirimine bears US NLM identifiers UMLS ID C0054150 and NCI Concept Code C1024. SMILES: C1=CC=C(C=C1)C2=C(C(=O)N=C(N2)N)BR.
Same parent
Under 51201800 · 28Activities that produce or sell this
KBLI · 8Inherited from family 51200000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.